Share:
The European Medicines Agency (EMA) recommended extra doses and boosters of the COVID-19 vaccines Comirnaty (BioNTech/Pfizer) and Spikevax (Moderna), and assessed cases of adverse events following vaccination with Vaxzevria (AstraZeneca COVID-19 Vaccine) and COVID-19 Vaccine Janssen:
- Comirnaty and Spikevax: EMA recommendations on extra doses and boosters
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.